Dr. E. Premkumar Reddy and Colleagues
Professor and Director, Department of Oncological Sciences
Mount Sinai School of Medicine, New York, NY
Medicinal chemistry, cell cycle and molecular mechanism studies
Supported in part by SBIR Grants
Dr. James F. Holland and Colleagues
Distinguished Professor of Neoplastic Diseases
Professor of Medicine, Hematology & Medical Oncology
Mount Sinai School of Medicine, New York, NY
Preclinical and Clinical Development of ON 01910.Na
Supported in part by the Martell Foundation
Dr. Jerome E. Groopman
Dina and Raphael Recanati Chair of Medicine, Harvard Medical School
Chief of Experimental Medicine
Beth Israel Deaconess Medical Center, Boston, MA
Cell Cycle-Directed Compounds for Mantle Cell Lymphoma
Supported in part by SBIR Grants
Dr. Antonio Jimeno
Director, Developmental Therapeutics/Pharmacodynamic Laboratory
University of Colorado Cancer Center, Aurora, CO
Evaluation of ON 01910.Na in Head and Neck Cancer models
Gene expression signatures to predict activity in solid tumors
Dr. Xavier Grana
Associate Professor of Biochemistry
Fels Institute for Cancer Research & Molecular Biology
Temple University School of Medicine
Philadelphia, PA 19140
Novel CDK inhibitors for HIV Therapy